Potential 'holy grail' nasal spray that may protect against COVID-19, flu and pneumonia aims for human trials
Potential 'holy grail' nasal spray that may protect against COVID-19, flu and pneumonia aims for human trials is drawing significant interest across the industry.
Stanford's potential universal vaccine promises to shield against COVID, flu, and more. Could one spray change how we fight respiratory threats? (Adobe Photo)
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- KMRL, IISc Bengaluru ink pact for research on sustainable urban mobility
- Opinion | Peace in Ukraine will require pragmatic diplomacy on both sides
- Dow Jones Erases 2026 Gains as Blue Chip Stocks Fail and Capital Flows Elsewhere
- AI a huge opportunity and serious risk for climate: UNEP official
Source: Original →